These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 120478)

  • 21. Stress-responsive neuromodulators.
    Gold PW
    Biol Psychiatry; 1988 Aug; 24(4):371-4. PubMed ID: 3044453
    [No Abstract]   [Full Text] [Related]  

  • 22. Clonidine treatment of the opiate withdrawal syndrome. A review of clinical trials of a theory.
    Agren H
    Acta Psychiatr Scand Suppl; 1986; 327():91-113. PubMed ID: 3529831
    [No Abstract]   [Full Text] [Related]  

  • 23. Clonidine and the primate locus coeruleus: evidence suggesting anxiolytic and anti-withdrawal effects.
    Redmond DE
    Prog Clin Biol Res; 1981; 71():147-63. PubMed ID: 6276892
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New concepts and treatments for anxiety.
    Covi L
    Md Med J; 1986 Oct; 35(10):821. PubMed ID: 3784798
    [No Abstract]   [Full Text] [Related]  

  • 25. Endorphin-locus coeruleus connection mediates opiate action and withdrawal.
    Gold MS; Byck R; Sweeney DR; Kleber HD
    Biomedicine; 1979 Feb; 30(1):1-4. PubMed ID: 223678
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence for the involvement of excitatory amino acid pathways in the development of precipitated withdrawal from acute and chronic morphine: an in vivo voltammetric study in the rat locus coeruleus.
    Hong M; Milne B; Jhamandas K
    Brain Res; 1993 Sep; 623(1):131-41. PubMed ID: 8221081
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuroanatomical sites of action of clonidine in opiate withdrawal: the locus coeruleus connection.
    Gold MS; Pottash AC; Extein IL; Kleber HD
    Prog Clin Biol Res; 1981; 71():285-98. PubMed ID: 6276897
    [No Abstract]   [Full Text] [Related]  

  • 28. Injections of an opioid antagonist into the locus coeruleus and periaqueductal gray but not the amygdala precipitates morphine withdrawal in the 7-day-old rat.
    Jones KL; Barr GA
    Synapse; 2001 Feb; 39(2):139-51. PubMed ID: 11180501
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Yohimbine premedication and 35% CO2 vulnerability in healthy volunteers.
    Pols H; Griez E; Verburg K; van der Werf D
    Eur Arch Psychiatry Clin Neurosci; 1994; 244(2):81-5. PubMed ID: 7948058
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fear extinction can be made state-dependent on peripheral epinephrine: role of norepinephrine in the nucleus tractus solitarius.
    Rosa J; Myskiw JC; Furini CR; Sapiras GG; Izquierdo I
    Neurobiol Learn Mem; 2014 Sep; 113():55-61. PubMed ID: 24161888
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of angiotensin type 2 receptor on secretion of the locus coeruleus in stress-induced hypertension rats.
    Gong WK; Lü J; Wang F; Wang B; Wang MY; Huang HP
    Brain Res Bull; 2015 Feb; 111():62-8. PubMed ID: 25562714
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dipropylacetate-induced quasi-morphine abstinence behaviour in the rat: participation of the locus coeruleus system.
    van der Laan JW; Bruinvels J; Cools AR
    Brain Res; 1982 Sep; 247(2):309-14. PubMed ID: 6812857
    [No Abstract]   [Full Text] [Related]  

  • 33. Involvement of locus coeruleus projections in opiate withdrawal but not in opiate tolerance in mice.
    Dossin O; Hanoun N; Zajac JM
    Eur J Pharmacol; 1996 Jul; 308(3):271-4. PubMed ID: 8858297
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Buspirone increases locus coeruleus noradrenergic neuronal activity in vitro.
    Trulson ME; Henderson LJ
    Eur J Pharmacol; 1984 Oct; 106(1):195-7. PubMed ID: 6529967
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Convulsive and non-convulsive ethanol withdrawal behaviour in rats with lesions of the noradrenergic locus coeruleus system.
    Clemmesen L; Lindvall O; Hemmingsen R; Ingvar M; Bolwig TG
    Brain Res; 1985 Oct; 346(1):164-7. PubMed ID: 4052765
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Behavior and anxiety: physiologic mechanisms.
    Lader M
    J Clin Psychiatry; 1983 Nov; 44(11 Pt 2):5-11. PubMed ID: 6643413
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NMDA receptor antagonists suppress behaviors but not norepinephrine turnover or locus coeruleus unit activity induced by opiate withdrawal.
    Rasmussen K; Fuller RW; Stockton ME; Perry KW; Swinford RM; Ornstein PL
    Eur J Pharmacol; 1991 May; 197(1):9-16. PubMed ID: 1832640
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Noradrenergic mechanisms involved in muscle relaxation: significance for the treatment of spasticity.
    Wiesendanger M; Corboz M; Palmeri A; Chen DF; Palmer CI
    Schweiz Arch Neurol Psychiatr (1985); 1991; 142(2):132-4. PubMed ID: 1710385
    [No Abstract]   [Full Text] [Related]  

  • 39. Locus coeruleus and norepinephrine in Parkinson's disease.
    Chan-Palay V
    Jpn J Psychiatry Neurol; 1991 Jun; 45(2):519-21. PubMed ID: 1722263
    [No Abstract]   [Full Text] [Related]  

  • 40. The locus ceruleus and anxiety disorders in demented and nondemented familial parkinsonism.
    Lauterbach EC
    Am J Psychiatry; 1993 Jun; 150(6):994. PubMed ID: 8494098
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.